Accord

Pemetrexed

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Accord

Pemetrexed HCPCS:

J9296

HCPCS Code Descriptor:

Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg

Category:

J Code

Pemetrexed NDCs:

16729-0522-64, 16729-0522-05, 16729-0522-28, 16729-0522-35

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Pemetrexed CPT Codes:

Potential CPT administration codes for Pemetrexed can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

16729-0522-64, 16729-0522-05, 16729-0522-28, 16729-0522-35

About Pemetrexed:

Pemetrexed is an Oncology drug manufactured by Accord and administered via the Intravenous route of administration. The J Code: J9296 is aligned to the drug Pemetrexed.

ACCESS PRICING AND MORE BY REGISTERING

J9296 Added Date:

April 1, 2023

J9296 Effective Date:

April 1, 2023

J9296 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Pemetrexed billing and coding information.
Our team did not identify a source for Pemetrexed patient assistance information. Please reach out to our team if you feel that this is a mistake.
Pemetrexed prescribing information can be found at the link below:
Information regarding Pemetrexed’s side effects can be found at MedlinePlus